BiomX (PHGE) Current Taxes (2018 - 2019)

BiomX's (PHGE) quarterly Current Taxes came in at $87713.0 in Q3 2019, down 35.7% quarter-over-quarter from $136419.0 in Q2 2019.

Analysis

BiomX (PHGE) Current Taxes (2018 - 2019) Analysis & Trends

BiomX has disclosed Current Taxes across 2 years of filings, most recently posting $87713.0 for Q3 2019.

In Q3 2019, Current Taxes changed N/A year-over-year to $87713.0; the TTM figure through Sep 2019 stood at $87713.0 (changed N/A YoY), while the FY2019 annual figure was $136419.0, changed N/A from the prior year.
Current Taxes came in at $87713.0 for Q3 2019 at BiomX, down from $136419.0 in the prior quarter.
In the past five years, Current Taxes ranged from a high of $136419.0 in Q2 2019 to a low of $8212.0 in Q4 2018.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Amgen	236.37 Bn	222.38 Bn	7.24 Bn	-
2	Gilead Sciences	187.38 Bn	184.12 Bn	6.22 Bn	-
3	Vertex Pharmaceuticals	138.36 Bn	130.51 Bn	2.84 Bn	-
4	Regeneron Pharmaceuticals	85.09 Bn	77.10 Bn	3.93 Bn	-
5	Argenx Se	63.93 Bn	58.75 Bn	1.37 Bn	49.00 Mn
6	Moderna	58.07 Bn	52.94 Bn	52.00 Mn	-
7	Alnylam Pharmaceuticals	35.59 Bn	32.28 Bn	992.69 Mn	-
8	Biogen	32.63 Bn	31.34 Bn	1.96 Bn	86.90 Mn
9	Insmed	27.57 Bn	26.41 Bn	358.27 Mn	-
10	BiomX	1.55 Mn	7.73 Mn	97,000.00	-

Historic Data

Download Data